| P2093 | author name string | Hong Hu | |
| | Zhenglei Xu | |
| | Bin Peng | |
| | Shaolin Lin | |
| | Huaisheng Chen | |
| | Zhanpeng Rao | |
| | Yingcai Hong | |
| P2860 | cites work | Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity | Q24292793 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 |
| | The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase | Q29618387 |
| | Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology | Q30311912 |
| | Immunohistochemical assessment of protein phosphorylation state: the dream and the reality | Q30441231 |
| | Barrett's oesophagus: epidemiology, cancer risk and implications for management | Q34375216 |
| | The versatile functions of Sox9 in development, stem cells, and human diseases | Q35077784 |
| | SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway. | Q35741056 |
| | Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma | Q35870326 |
| | ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer | Q36413318 |
| | Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. | Q36841557 |
| | A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway | Q37224355 |
| | Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy | Q37428314 |
| | The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer | Q38053414 |
| | Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers | Q38073246 |
| | A global assessment of the oesophageal adenocarcinoma epidemic | Q38430776 |
| | SOX9 drives WNT pathway activation in prostate cancer | Q38780862 |
| | Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance | Q38860383 |
| | Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. | Q38941897 |
| | MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway | Q39063949 |
| | Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation | Q39157139 |
| | SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion | Q40002614 |
| | SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells | Q40181725 |
| | Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. | Q50643429 |
| | SOX9 expression predicts relapse of stage II colon cancer patients. | Q53147256 |
| | Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries | Q61646429 |
| | Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients | Q74268762 |
| | Adenocarcinoma of the esophago-gastric junction | Q79648257 |
| | The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 |
| | Elevated expression of SOX9 is related with the progression of gastric carcinoma | Q83367591 |
| | Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands | Q83407996 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| | trastuzumab | Q412616 |
| P304 | page(s) | 3103-3107 | |
| P577 | publication date | 2018-01-12 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction | |
| P478 | volume | 15 | |